As Programmed death-ligand 1 (PD-L1) expression has been found on the surface of glioblastoma-derived EVs, the presence of PD-L1 can indicate resistance to immune checkpoint inhibitors such as anti-PD-1 [35]. This evidence concerns the gene CD274 and glioblastoma.